WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/083440    International Application No.:    PCT/US2005/047297
Publication Date: 10.08.2006 International Filing Date: 29.12.2005
C07D 471/14 (2006.01), C07D 471/22 (2006.01), A61K 31/437 (2006.01)
Applicants: 3M INNOVATIVE PROPERTIES COMPANY [US/US]; 3M Center, Post Office Box 33427, Saint Paul, MN 55133-3427 (US) (For All Designated States Except US).
GRIESGRABER, George, W., [US/US]; (US) (For US Only).
KSHIRSAGAR, Tushar, A., [IN/US]; (US) (For US Only).
SLANIA, Sarah, J. [US/US]; (US) (For US Only).
DANIELSON, Michael, E., [US/US]; (US) (For US Only)
Inventors: GRIESGRABER, George, W.,; (US).
KSHIRSAGAR, Tushar, A.,; (US).
SLANIA, Sarah, J.; (US).
DANIELSON, Michael, E.,; (US)
Agent: ERSFELD, Dean, A.,; 3M Center, Office of Intellectual Property Counsel, Post Office Box 33427, Saint Paul, MN 55133-3427 (US)
Priority Data:
60/640,440 30.12.2004 US
60/697,256 07.07.2005 US
Abstract: front page image
(EN)Substituted fused [1,2]imidazo[4,5-c] ring compounds (e.g., imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, and 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines) with a -CH(-R1)- group in the fused ring at the 1-position of the imidazo ring, wherein Rl includes a functional group, for example, an amide, sulfonamide, urea, carbamate, ester, ketone, ether, a thio analog of the forgoing, sulfone, oxime, or hydroxylamine, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
(FR)L'invention concerne des composés [1,2]imidazo[4,5-c] substitués à noyau fusionné (par exemple, des imidazo[4,5-c]quinolines, des 6,7,8,9-tétrahydroimidazo[4,5-c]quinolines, des imidazo[4,5-c]naphthyridines et des 6,7,8,9-tétrahydroimidazo[4,5-c]naphthyridines) comprenant un groupe -CH(-R1)- dans le noyau fusionné au niveau de la position 1 du noyau imidazo, dans lequel Rl comprend un groupe fonctionnel, par exemple, un amide, un sulfonamide, une urée, un carbamate, un ester, un cétone, un éther, un analogue thio des éléments susmentionnés, un sulfone, un oxime ou un hydroxylamine. L'invention concerne également des compositions pharmaceutiques contenant lesdits composés, des intermédiaires, des procédés de préparation des composés, des procédés d'utilisation comme immunomodulateurs permettant d'induire la biosynthèse de la cytokine chez les animaux et de traiter des maladies notamment des maladies virales et néoplasiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)